Bioceres Crop Solutions (BIOX)
(Delayed Data from NSDQ)
$3.32 USD
-0.05 (-1.48%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $3.30 -0.02 (-0.60%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BIOX 3.32 -0.05(-1.48%)
Will BIOX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BIOX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIOX
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates
BIOX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BIOX
Bioceres price target lowered by $1 at Oppenheimer, here's why
BIOX: Oppenheimer Adjusts Price Target for Bioceres Crop Solutions | BIOX Stock News
Bioceres Crop Solutions Announces Board of Directors Changes
Bioceres Crop Solutions (BIOX) Receives a Buy from Lake Street
Bioceres Crop Solutions Announces Changes to Board of Directors | BIOX Stock News